Supporting scientific research for longer, healthier lives
The Longer Life Foundation, and our ongoing active role in it since its founding, reflects RGA’s long-standing commitment to corporate social responsibility and our passion for improving people’s lives.
Dr. Dan Zimmerman
Senior Vice President, Head of Global Medical and Managing Director, Longer Life Foundation
The Longer Life Foundation (LLF), a collaboration between RGA and Washington University School of Medicine in St. Louis, is now in its 23rd year of supporting and funding research to improve long-term mortality, enhance longevity, and promote health and wellness. This not-for-profit organization supports innovative, early-stage independent research by scientific, medical, and public health experts.
In 2020 LLF awarded seven grants, one of which was a special interim grant to investigate potential predictive biomarkers of more serious COVID-19 disease. This research may allow doctors to identify, early in the course of disease, which patients might be at the highest risk of experiencing severe outcomes and potentially help improve morbidity and mortality outcomes.
Since its founding, LLF has funded more than 130 research projects, many of which have advanced clinical knowledge in their respective fields, including longevity, genomics, obesity, older-age cognition, heart disease, and cancer.
In addition, more than 150 publications by LLF-funded researchers have been published in peer-reviewed scientific journals, and LLF researchers are frequently quoted in the consumer press. Public health has benefited as well, as LLF-funded discoveries are enabling more effective assessment, diagnosis, treatment, and even prevention of many common diseases and conditions.
LLF has also received excellent feedback from the insurance industry, including growing involvement and participation by client companies with an aim to increase awareness globally. The foundation, and our ongoing active role in it since its founding, reflects RGA’s long-standing commitment to corporate social responsibility and our passion for improving people’s lives.
Dr. Dan Zimmerman
Senior Vice President, Head of Global Medical
Dr. Dave Rengachary
Senior Vice President, Chief Medical Director, U.S. Mortality Markets
RGA medical directors provide expert insights during pandemic
“The medical team equipped clients with a deeper understanding of the latest mortality, morbidity, and healthcare developments and trends.”